Sable Bio

Sable – Navigate Drug Safety with Augmented Intelligence

London, United Kingdom · Founded 2023 · $5.7M raised

Headquarters
London
Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$5.7M
Last Round
$3.8M SeedFeb 2026
Rounds
2

About

AI-powered drug safety platform that generates toxicology insights from unstructured trial data to accelerate drug discovery.

Summary

Sable Bio is a Biotech company based in London, United Kingdom, founded in 2023. It has raised $5.7M in total across 2 rounds, most recently a $3.8M Seed round in Feb 2026. Investors include Episode 1 Ventures, MMC Ventures and Seedcamp.

Tech & App Stack

1 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

SeedSeed RoundFeb 2026
$3.8M

Sign up to see all 2 rounds

Pre-Seed through Seed — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sable Bio on Indexed.vc
<a href="https://indexed.vc/companies/sable-bio"><img src="https://indexed.vc/api/badge/company/sable-bio" alt="Sable Bio on Indexed.vc" width="260" height="76" /></a>